by Bruce McEwen, Ph.D; Ana C. Pereira, M.D.
Goal: Investigators will conduct an initial clinical study of the drug Riluzole in a small number of adults with mild cognitive impairment to see whether it decreases metabolic changes in the brain that may be associated with progression to Alzheimer...Read more >
by Sheila Blumstein, Ph.D.
This pilot study will explore the potential efficacy of a targeted speech therapy program in improving speech sounds and ultimately communication by patients who developed aphasia as a result of a stroke.
Stroke-induced injuries to the brain can r...Read more >
by Emad Eskandar, M.D.
This neurosurgical research team will explore, at the neuronal level, how two brain networks normally drive the balance between safe and risky decision-making behaviors, and use the findings to design deep brain stimulation (DBS) strategies for modif...Read more >
by Stephan Mayer, M.D.
Investigators will create the capacity to graphically display real-time brain physiologic changes in comatose patients to guide urgent clinical interventions to prevent further damage.
Continuous multimodal monitoring systems that measure and recor...Read more >
by Huntington Potter, Ph.D.
Investigators will undertake the second phase of their clinical study to determine in a small number of people with Alzheimer’s disease whether the drug Leukine shows promise in improving patients’ cognitive abilities and arrests brain atrophy.
Abou...Read more >
by Guy McKhann, M.D.
This study will continue an
assessment of whether the increased risk of stroke in older patients who
undergo a catheter-based rather than surgical replacement of their aortic valve
is associated with the technique or with their underlying vas...Read more >